The report "Intraocular Lens Market by Type (Monofocal IOLs (Spheric Monofocal IOLs), Premium IOLs (Accommodating IOLs)), Material (Hydrophobic Acrylic IOLs, PolyMethylMethAcrylate, Silicon IOLs), Application (Presbyopia), End User (Hospitals) - Global Forecast to 2030 ", is projected to reach USD 6.17 billion by 2030 from USD 4.62 billion in 2025, at a CAGR of 6.0% during the forecast period.

Browse 222 market data Tables and 50 Figures spread through 239 Pages and in-depth TOC on "Intraocular Lens Market by Type (Monofocal IOLs (Spheric Monofocal IOLs), Premium IOLs (Accommodating IOLs)), Material (Hydrophobic Acrylic IOLs, PolyMethylMethAcrylate, Silicon IOLs), Application (Presbyopia), End User (Hospitals) - Global Forecast to 2030 "

Download PDF - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=263730551

The intraocular lens market is driven by the rising prevalence of cataracts, the rapid adoption of premium lenses, and technological advancements that improve surgical outcomes. However, the high cost of premium IOLs and limited reimbursement in developing regions restrain adoption. Opportunities arise from expanding healthcare access in emerging markets, increasing demand for personalized optics, and ongoing innovations such as EDOF and presbyopia-correcting lenses that enhance visual performance and broaden the market’s value potential.

The aspheric monofocal IOLs segment held the largest share of the monofocal IOLs market in 2024.

Aspheric monofocal IOLs hold the largest market share because they offer reliable visual outcomes, improved contrast sensitivity, and reduced spherical aberrations at an affordable cost. Their strong clinical performance, wide surgeon preference, and broad reimbursement coverage make them the standard choice for routine cataract surgeries. High patient acceptance and consistent availability across global markets further reinforce their dominant position.

The cataract surgery segment held the largest share of the intraocular lens market, by application, in 2024.

Cataract surgery holds the largest market share in the IOLs market because it is the most commonly performed ophthalmic procedure worldwide, driven by the rising prevalence of cataracts and aging populations. IOL implantation is a standard part of cataract treatment, ensuring consistent demand. Technological advancements, improved surgical outcomes, and widespread reimbursement support further strengthen the dominance of this application segment in the overall IOLs market.

In 2024, North America accounted for the largest share of the intraocular lens market.

North America holds the largest market share in the IOLs market due to its high volume of cataract surgeries, advanced ophthalmic infrastructure, and strong adoption of premium and technologically advanced IOLs. Favorable reimbursement policies, widespread availability of skilled surgeons, and continuous innovation from leading manufacturers further strengthen regional leadership. Additionally, high patient awareness, early adoption of new technologies, and strong healthcare spending contribute to North America’s dominant position in the global IOLs market.

Key Market Players

Prominent players in the intraocular lens market are Alcon (US), Johnson & Johnson Vision Care, Inc. (US), Carl Zeiss Meditec AG (Germany), HOYA Corporation (Japan), Bausch + Lomb (US), Santen Pharmaceutical Co., Ltd. (Japan), NIDEK CO., LTD. (Japan), Lenstec, Inc. (US), Rayner Group (England), BVI (US), OPHTEC B.V. (Netherlands), SAV-IOL SA (Switzerland), Appasamy Associates Private Limited (India), Atia Vision, Inc. (US), and Biotech (Switzerland), among others.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.